Q1 2023 Holdings
Filed 2023-05-15 | 41 holdings | $1.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biolife Solutions Inc(BLFS) | COM NEW | 09062W204 | $164.7M | 7,571,535 | 13.6% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $159.9M | 1,160,000 | 13.2% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $93.9M | 5,698,574 | 7.7% |
| Eqrx Inc | COM | 26886C107 | $76.7M | 39,527,669 | 6.3% |
| Illumina Inc(ILMN) | COM | 452327109 | $64.0M | 275,000 | 5.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $54.1M | 270,000 | 4.5% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $47.5M | 1,275,000 | 3.9% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $44.6M | 1,675,000 | 3.7% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $39.2M | 1,810,000 | 3.2% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $38.3M | 565,000 | 3.2% |
| Genedx Holdings Corp(SMFRUSD) | COM CL A | 81663L101 | $37.3M | 102,151,785 | 3.1% |
| Somalogic Inc(SLGCUSD) | CLASS A COM | 83444K105 | $32.1M | 12,604,275 | 2.6% |
| Verve Therapeutics Inc | COM | 92539P101 | $30.6M | 2,120,571 | 2.5% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $30.1M | 670,000 | 2.5% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $30.0M | 1,300,000 | 2.5% |
| Maxcyte Inc(MXCT) | COM | 57777K106 | $24.4M | 4,925,000 | 2.0% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $20.6M | 2,023,913 | 1.7% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $19.0M | 2,520,000 | 1.6% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $19.0M | 510,000 | 1.6% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $18.4M | 1,070,000 | 1.5% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $17.5M | 570,000 | 1.4% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $17.3M | 6,078,860 | 1.4% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $16.1M | 677,017 | 1.3% |
| Prometheus Biosciences Inc | COM | 74349U108 | $16.1M | 150,000 | 1.3% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $13.0M | 850,000 | 1.1% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $11.7M | 2,050,000 | 1.0% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $11.1M | 3,206,380 | 0.9% |
| Twist Bioscience Corp(TWST) | COM | 90184D100 | $10.6M | 700,000 | 0.9% |
| Absci Corporation(ABSI) | COM | 00091E109 | $9.4M | 5,393,260 | 0.8% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $9.0M | 734,350 | 0.7% |
| Dice Therapeutics Inc | COM | 23345J104 | $8.9M | 310,000 | 0.7% |
| Optimizerx Corp(OPRX) | COM NEW | 68401U204 | $7.3M | 500,000 | 0.6% |
| Incyte Corp(INCY) | COM | 45337C102 | $5.6M | 77,500 | 0.5% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $4.0M | 510,882 | 0.3% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $4.0M | 1,000,000 | 0.3% |
| Sarepta Therapeutics Inc(SRPT)Call | COM | 803607100 | $3.4M | 25,000 | 0.3% |
| Singular Genomics Systems in | COM | 82933R100 | $1.6M | 1,345,722 | 0.1% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $1.4M | 1,038,388 | 0.1% |
| Exscientia PLC | ADS | 30223G102 | $1.1M | 213,900 | 0.1% |
| Lianbio | SPONSORED ADS | 53000N108 | $402.5K | 206,415 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $180.8K | 123,839 | 0.0% |